Literature DB >> 16116114

Aggregation of vascular risk factors and risk of incident Alzheimer disease.

J A Luchsinger1, C Reitz, L S Honig, M X Tang, Steven Shea, R Mayeux.   

Abstract

BACKGROUND: The prevalence of Alzheimer disease (AD) is increasing in the elderly, and vascular risk factors may increase its risk.
OBJECTIVE: To explore the association of the aggregation of vascular risk factors with AD.
METHODS: The authors followed 1,138 individuals without dementia at baseline (mean age 76.2) for a mean of 5.5 years. The presence of vascular risk factors was related to incident possible and probable AD.
RESULTS: Four risk factors (diabetes, hypertension, heart disease, and current smoking) were associated with a higher risk of AD (p < 0.10) when analyzed individually. The risk of AD increased with the number of risk factors (diabetes + hypertension + heart disease + current smoking). The adjusted hazards ratio of probable AD for the presence of three or more risk factors was 3.4 (95% CI: 1.8, 6.3; p for trend < 0.0001) compared with no risk factors. Diabetes and current smoking were the strongest risk factors in isolation or in clusters, but hypertension and heart disease were also related to a higher risk of AD when clustered with diabetes, smoking, or each other.
CONCLUSIONS: The risk of Alzheimer disease (AD) increased with the number of vascular risk factors. Diabetes and current smoking were the strongest risk factors, but clusters including hypertension and heart disease also increased the risk of AD. These associations are unlikely to be explained by misclassification of the outcome, given strong associations when only probable AD is considered.

Entities:  

Mesh:

Year:  2005        PMID: 16116114      PMCID: PMC1619350          DOI: 10.1212/01.wnl.0000172914.08967.dc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  82 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

Authors:  P Eikelenboom; F C Stam
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

3.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

4.  Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid.

Authors:  M W Schwartz; A Sipols; S E Kahn; D F Lattemann; G J Taborsky; R N Bergman; S C Woods; D Porte
Journal:  Am J Physiol       Date:  1990-09

5.  Alzheimer's disease and senile brains: an immunofluorescence study.

Authors:  A Licandro; S Ferla; B Tavolato
Journal:  Riv Patol Nerv Ment       Date:  1983 Mar-Apr

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Cerebral changes in chronic hypertension: combined permeability and immunohistochemical studies.

Authors:  S Nag
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease.

Authors:  S M de la Monte
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

9.  Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study.

Authors:  M E Farmer; S J Kittner; R D Abbott; M M Wolz; P A Wolf; L R White
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

10.  A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

Authors:  A Brun; E Englund
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  281 in total

1.  Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.

Authors:  Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-05

2.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

Review 3.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Type 2 diabetes and ethnic disparities in cognitive impairment.

Authors:  James M Noble; Jennifer J Manly; Nicole Schupf; Ming-Xing Tang; José A Luchsinger
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

Review 6.  Vascular risk factors and dementia: how to move forward?

Authors:  Anand Viswanathan; Walter A Rocca; Christophe Tzourio
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

7.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

8.  Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.

Authors:  Jeremy J Pruzin; Julie A Schneider; Ana W Capuano; Sue E Leurgans; Lisa L Barnes; Rexford S Ahima; Steven E Arnold; David A Bennett; Zoe Arvanitakis
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

Review 9.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.

Authors:  Jun Ku Chung; Shinichiro Nakajima; Eric Plitman; Yusuke Iwata; Danielle Uy; Philip Gerretsen; Fernando Caravaggio; M Mallar Chakravarty; Ariel Graff-Guerrero
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-29       Impact factor: 4.105

10.  Cardiovascular risks and brain function: a functional magnetic resonance imaging study of executive function in older adults.

Authors:  Yi-Fang Chuang; Dana Eldreth; Kirk I Erickson; Vijay Varma; Gregory Harris; Linda P Fried; George W Rebok; Elizabeth K Tanner; Michelle C Carlson
Journal:  Neurobiol Aging       Date:  2013-12-18       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.